- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 4.20 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schatz-Jakobsen, J.A. et al., Structural Basis for Eculizumab-Mediated Inhibition of the Complement Terminal Pathway. J Immunol. (2016)
- Release Date
- 2016-03-16
- Peptides
- Complement C5: A
Eculizumab heavy chain (variable domain): B
Eculizumab light chain (variable domain): C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
XC
Y